Dentsu Creative India has won the digital creative mandate for healthcare brands Shelcal and Unienzyme from Torrent Pharmaceuticals. The account was won following a multi-agency pitch and will be handled by the agency’s Mumbai office.
An official statement informed that the two brands are making their debut in the OTC (Over-the-Counter) market.
The stated aim is to delve into lesser-known health topics in India, particularly focusing on calcium deficiency and gut health. The objective is to develop effective communication and educational campaigns that not only attract new customers but also cultivate stronger brand loyalty among existing ones.
Sahil Shah, President – Digital Experience, Dentsu Creative India, said, “With Torrent Pharmaceuticals venturing into the OTC segment with significant plans, we felt it was the right time to partner up and address their digital creative activations. Together, we have embarked on a journey to revolutionise their digital marketing in this ‘waiting to innovate’ OTC healthcare domain. I am grateful for their trust in Dentsu Creative and confident that we will blend innovation and creativity to craft messages that truly resonate, fostering meaningful connections with audiences.”
Manika Juneja, Managing Partner, Dentsu Creative India, added, “Torrent Pharma’s digital creative mandate is a step forward in strengthening Dentsu Creative’s portfolio within the pharmaceutical category of brands. We are thrilled about this new victory and look forward to a stronger and fruitful partnership with lots of exciting work inspired by ‘Modern Creativity’ in the near future.”
Feedback: [email protected]
